TY  - JOUR
T1  - The prospective, observational, multicenter, major trauma transfusion (prommtt) study: Comparative effectiveness of a time-varying treatment with competing risks
AU  - Holcomb JB, del Junco DJ, Fox EE, et al
Y1  - 2013/02/01
N1  - 10.1001/2013.jamasurg.387
JO  - JAMA Surgery
SP  - 127
EP  - 136
VL  - 148
IS  - 2
N2  - Objective 
                  To relate in-hospital mortality to early transfusion of plasma and/or platelets and to time-varying plasma:red blood cell (RBC) and platelet:RBC ratios.Design 
                  Prospective cohort study documenting the timing of transfusions during active resuscitation and patient outcomes. Data were analyzed using time-dependent proportional hazards models.Setting 
                  Ten US level I trauma centers.Patients 
                  Adult trauma patients surviving for 30 minutes after admission who received a transfusion of at least 1 unit of RBCs within 6 hours of admission (n = 1245, the original study group) and at least 3 total units (of RBCs, plasma, or platelets) within 24 hours (n = 905, the analysis group).Main Outcome Measure 
                  In-hospital mortality.Results 
                  Plasma:RBC and platelet:RBC ratios were not constant during the first 24 hours (P < .001 for both). In a multivariable time-dependent Cox model, increased ratios of plasma:RBCs (adjusted hazard ratio = 0.31; 95% CI, 0.16-0.58) and platelets:RBCs (adjusted hazard ratio = 0.55; 95% CI, 0.31-0.98) were independently associated with decreased 6-hour mortality, when hemorrhagic death predominated. In the first 6 hours, patients with ratios less than 1:2 were 3 to 4 times more likely to die than patients with ratios of 1:1 or higher. After 24 hours, plasma and platelet ratios were unassociated with mortality, when competing risks from nonhemorrhagic causes prevailed.Conclusions 
                  Higher plasma and platelet ratios early in resuscitation were associated with decreased mortality in patients who received transfusions of at least 3 units of blood products during the first 24 hours after admission. Among survivors at 24 hours, the subsequent risk of death by day 30 was not associated with plasma or platelet ratios.
SN  - 2168-6254
M3  - doi: 10.1001/2013.jamasurg.387
UR  - http://dx.doi.org/10.1001/2013.jamasurg.387
ER  -